354 related articles for article (PubMed ID: 9768567)
1. Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors.
Smith RL; Canton H; Barrett RJ; Sanders-Bush E
Pharmacol Biochem Behav; 1998 Nov; 61(3):323-30. PubMed ID: 9768567
[TBL] [Abstract][Full Text] [Related]
2. The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.
Carbonaro TM; Eshleman AJ; Forster MJ; Cheng K; Rice KC; Gatch MB
Psychopharmacology (Berl); 2015 Jan; 232(1):275-84. PubMed ID: 24985890
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
Newton RA; Phipps SL; Flanigan TP; Newberry NR; Carey JE; Kumar C; McDonald B; Chen C; Elliott JM
J Neurochem; 1996 Dec; 67(6):2521-31. PubMed ID: 8931486
[TBL] [Abstract][Full Text] [Related]
4. 1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonist.
Nichols DE; Frescas S; Marona-Lewicka D; Huang X; Roth BL; Gudelsky GA; Nash JF
J Med Chem; 1994 Dec; 37(25):4346-51. PubMed ID: 7996545
[TBL] [Abstract][Full Text] [Related]
5. Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.
Blair JB; Kurrasch-Orbaugh D; Marona-Lewicka D; Cumbay MG; Watts VJ; Barker EL; Nichols DE
J Med Chem; 2000 Nov; 43(24):4701-10. PubMed ID: 11101361
[TBL] [Abstract][Full Text] [Related]
6. Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine.
Blair JB; Marona-Lewicka D; Kanthasamy A; Lucaites VL; Nelson DL; Nichols DE
J Med Chem; 1999 Mar; 42(6):1106-11. PubMed ID: 10090793
[TBL] [Abstract][Full Text] [Related]
7. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
Zaniewska M; McCreary AC; Przegaliński E; Filip M
Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
[TBL] [Abstract][Full Text] [Related]
8. Regulation of serotonin 5-HT2C receptors in the rat choroid plexus after acute clozapine treatment.
Kuoppamäki M; Seppälä T; Syvälahti E; Hietala J
Eur J Pharmacol; 1994 Oct; 269(2):201-8. PubMed ID: 7851496
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor.
Smith RL; Barrett RJ; Sanders-Bush E
Psychopharmacology (Berl); 1999 Jun; 144(3):248-54. PubMed ID: 10435391
[TBL] [Abstract][Full Text] [Related]
10. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
[TBL] [Abstract][Full Text] [Related]
11. ALEPH-2, a suspected anxiolytic and putative hallucinogenic phenylisopropylamine derivative, is a 5-HT2a and 5-HT2c receptor agonist.
Acuña-Castillo C; Scorza C; Reyes-Parada M; Cassels BK; Huidobro-Toro JP
Life Sci; 2000 Nov; 67(26):3241-7. PubMed ID: 11191631
[TBL] [Abstract][Full Text] [Related]
12. Substituted hexahydrobenzodipyrans as 5-HT2A/2C receptor probes.
Whiteside MS; Kurrasch-Orbaugh D; Marona-Lewicka D; Nichols DE; Monte A
Bioorg Med Chem; 2002 Oct; 10(10):3301-6. PubMed ID: 12150876
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with citalopram and buspirone: effects on serotonin 5-HT2A and 5-HT2C receptors in the rat brain.
Syvälahti E; Penttilä J; Majasuo H; Pälvimäki EP; Laakso A; Hietala J
Pharmacopsychiatry; 2006 Jan; 39(1):1-8. PubMed ID: 16453246
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
15. Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors.
Nelson DL; Lucaites VL; Wainscott DB; Glennon RA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):1-6. PubMed ID: 9933142
[TBL] [Abstract][Full Text] [Related]
16. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
[TBL] [Abstract][Full Text] [Related]
17. 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.
Fiorella D; Helsley S; Rabin RA; Winter JC
Psychopharmacology (Berl); 1995 Dec; 122(3):237-43. PubMed ID: 8748393
[TBL] [Abstract][Full Text] [Related]
18. Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function.
Eshleman AJ; Forster MJ; Wolfrum KM; Johnson RA; Janowsky A; Gatch MB
Psychopharmacology (Berl); 2014 Mar; 231(5):875-88. PubMed ID: 24142203
[TBL] [Abstract][Full Text] [Related]
19. Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist but not antagonist binding to 5-HT2c receptors after chronic treatment.
Hietala J; Kuonnamäki M; Pälvimäki EP; Laakso A; Majasuo H; Syvälahti E
Psychopharmacology (Berl); 2001 Sep; 157(2):180-7. PubMed ID: 11594443
[TBL] [Abstract][Full Text] [Related]
20. Effects of 5-HT
Fletcher PJ; Zeeb FD; Browne CJ; Higgins GA; Soko AD
Psychopharmacology (Berl); 2017 Mar; 234(5):889-902. PubMed ID: 28097374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
